Concepedia

Amalendu P. Ranjan

AP

Statistics

Publications

25

Citations

1.1K

H-Index

18

Active since

2008

Affiliations

University of North Texas(Current)

University of North Texas Health Science Center

Bipar

SignPath Pharma (United States)

Yale University

Amalendu P. Ranjan is an author at University of North Texas specializing in engineering, medicine, and nanomedicine.

ORCID

Top concepts

Publications per year

2008–2024

25

Publications

25

Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer

Sanjay Thamake, Sangram Raut, Zygmunt Gryczyński et al. · Biomaterials · 2012 · 179 citations

, , +9

Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy

Amalendu P. Ranjan, Anindita Mukerjee, Lawrence Helson et al. · Journal of Nanobiotechnology · 2012 · 124 citations · Full text

Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.

Amalendu P. Ranjan, Anindita Mukerjee, Lawrence Helson et al. · PubMed · 2013 · 108 citations

Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials

Andrew Gdowski, K. V. B. Johnson, Sunil Shah et al. · Journal of Nanobiotechnology · 2018 · 76 citations · Full text

Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy

Sanjay Thamake, Sangram Raut, Amalendu P. Ranjan et al. · Nanotechnology · 2010 · 64 citations

, , +13

1–5 of 25